Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future.
about
Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib.Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells.Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44+/CD24- breast cancer stem cells.Cyclin-dependent kinase activity is required for type I interferon production.Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation.Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis.CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once ThoughtCirc-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6
P2860
Q38662999-25680187-B05D-45E8-8DE6-F5180A3326F9Q39055609-F6FFBD3B-FBA0-4392-BE25-29EDB35C3D2CQ39402106-D166FBC8-B384-4703-9663-512473A3CD66Q47121115-71B77443-4383-4396-BBC7-F22C33F1BFEDQ50054859-8D450553-6DBF-4A3D-A3FC-2FB5C5665AF7Q50105972-CC491A9C-4D66-4587-A831-B2A179482189Q52673244-EF0C5E9C-F354-4B49-BBA8-EE39E68C9D97Q54978831-55512B92-A087-4663-9CEC-C2D0547828ACQ55361350-685A2FD1-A5D1-41B1-946A-D999D8EE41A6Q57176702-75DFF6F4-F233-469C-A921-CB0A1C4F9C03Q58786576-B4E474A7-9F95-4157-AF5D-E0FF5A650EF2
P2860
Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cyclin-Dependent Kinase Inhibi ...... er: Past, Present, and Future.
@en
type
label
Cyclin-Dependent Kinase Inhibi ...... er: Past, Present, and Future.
@en
prefLabel
Cyclin-Dependent Kinase Inhibi ...... er: Past, Present, and Future.
@en
P2093
P2860
P356
P1433
P1476
Cyclin-Dependent Kinase Inhibi ...... er: Past, Present, and Future.
@en
P2093
Adam J DiPippo
Chad M Barnett
Neelam K Patel
P2860
P304
P356
10.1002/PHAR.1756
P407
P577
2016-04-18T00:00:00Z